iRhythm Holdings, Inc. Increase (Decrease) in Accounts Receivable
iRhythm Holdings, Inc. (IRTC) reported Increase (Decrease) in Accounts Receivable of $65.99 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $32.99M, a 23.13% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $33.00M, a 9.54% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $19.05M, a 18.01% decline year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $19.46M, a 112.36% increase year-over-year.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $95.43M, a 3.82% increase from fiscal 2024.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $91.92M, a 13.21% increase from fiscal 2023.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $81.19M, a 31.30% increase from fiscal 2022.
- iRhythm Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $61.84M, a 15.43% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $32.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $65.99M 10-Q · filed 2026-08-06 | $85.04M derived: sum of 3 quarters · filed 2026-08-06 | $104.50M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $33.00M 10-Q · filed 2026-04-30 | $52.05M derived: sum of 2 quarters · filed 2026-04-30 | $71.52M derived: sum of 3 quarters · filed 2026-04-30 | $98.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $38.52M derived: sum of 2 quarters · filed 2026-02-19 | $65.31M derived: sum of 3 quarters · filed 2026-08-06 | $95.43M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $19.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $46.25M derived: sum of 2 quarters · filed 2026-08-06 | $76.38M 10-Q · filed 2025-10-30 | $99.62M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $26.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $56.92M 10-Q · filed 2026-08-06 | $80.16M derived: sum of 3 quarters · filed 2026-08-06 | $89.32M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $30.13M 10-Q · filed 2026-04-30 | $53.37M derived: sum of 2 quarters · filed 2026-04-30 | $62.53M derived: sum of 3 quarters · filed 2026-04-30 | $77.53M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $23.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $32.40M derived: sum of 2 quarters · filed 2026-02-19 | $47.40M derived: sum of 3 quarters · filed 2026-02-19 | $91.92M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $9.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $24.16M derived: sum of 2 quarters · filed 2025-10-30 | $68.68M 10-Q · filed 2025-10-30 | $98.07M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $59.52M 10-Q · filed 2025-07-31 | $88.91M derived: sum of 3 quarters · filed 2026-02-19 | $102.03M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $44.52M 10-Q · filed 2025-05-01 | $73.91M derived: sum of 2 quarters · filed 2026-02-19 | $87.03M derived: sum of 3 quarters · filed 2026-02-19 | $104.65M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $29.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $42.52M derived: sum of 2 quarters · filed 2026-02-19 | $60.13M derived: sum of 3 quarters · filed 2026-02-19 | $81.19M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $13.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $30.74M derived: sum of 2 quarters · filed 2024-10-30 | $51.80M 10-Q · filed 2024-10-30 | $55.76M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $17.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $38.68M 10-Q · filed 2024-08-01 | $42.63M derived: sum of 3 quarters · filed 2025-02-20 | $60.31M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $21.06M 10-Q · filed 2024-05-02 | $25.02M derived: sum of 2 quarters · filed 2025-02-20 | $42.70M derived: sum of 3 quarters · filed 2025-02-20 | $60.02M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $21.64M derived: sum of 2 quarters · filed 2025-02-20 | $38.96M derived: sum of 3 quarters · filed 2025-02-20 | $61.84M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $17.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $35.00M derived: sum of 2 quarters · filed 2023-11-02 | $57.88M 10-Q · filed 2023-11-02 | $64.63M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $17.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $40.20M 10-Q · filed 2023-08-04 | $46.95M derived: sum of 3 quarters · filed 2024-02-22 | $46.10M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $22.88M 10-Q · filed 2023-05-04 | $29.63M derived: sum of 2 quarters · filed 2024-02-22 | $28.78M derived: sum of 3 quarters · filed 2024-02-22 | $36.63M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $5.90M derived: sum of 2 quarters · filed 2024-02-22 | $13.75M derived: sum of 3 quarters · filed 2024-02-22 | $53.57M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$848.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $7.00M derived: sum of 2 quarters · filed 2022-11-04 | $46.82M 10-Q · filed 2022-11-04 | $58.78M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $7.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $47.67M 10-Q · filed 2022-08-05 | $59.63M derived: sum of 3 quarters · filed 2023-02-23 | $72.63M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $39.82M 10-Q · filed 2022-05-06 | $51.77M derived: sum of 2 quarters · filed 2023-02-23 | $64.78M derived: sum of 3 quarters · filed 2023-02-23 | $67.79M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $11.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $24.96M derived: sum of 2 quarters · filed 2023-02-23 | $27.97M derived: sum of 3 quarters · filed 2023-02-23 | $37.96M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $13.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $16.01M derived: sum of 2 quarters · filed 2021-11-05 | $26.00M 10-Q · filed 2021-11-05 | $31.93M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $12.99M 10-Q · filed 2021-08-09 | $18.92M derived: sum of 3 quarters · filed 2022-02-28 | $22.30M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $9.99M 10-Q · filed 2021-05-10 | $15.92M derived: sum of 2 quarters · filed 2022-02-28 | $19.30M derived: sum of 3 quarters · filed 2022-02-28 | $26.32M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $5.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $9.31M derived: sum of 2 quarters · filed 2022-02-28 | $16.33M derived: sum of 3 quarters · filed 2022-02-28 | $28.73M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.40M derived: sum of 2 quarters · filed 2020-11-06 | $22.80M 10-Q · filed 2020-11-06 | $29.46M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $7.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $19.41M 10-Q · filed 2020-08-07 | $17.84M 10-Q · filed 2019-08-06 | $26.08M derived: sum of 3 quarters · filed 2021-02-26 | $29.96M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | $12.39M 10-Q · filed 2020-05-08 | $10.98M 10-Q · filed 2019-05-10 | $19.06M derived: sum of 2 quarters · filed 2021-02-26 | $22.94M derived: sum of 3 quarters · filed 2021-02-26 | $28.60M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2018-12-31 | $6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $10.55M derived: sum of 2 quarters · filed 2021-02-26 | $16.21M derived: sum of 3 quarters · filed 2021-02-26 | $21.75M 10-K · filed 2021-02-26 | $22.89M 10-K · filed 2019-03-04 | |||
| 2018-09-30 | $3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-23 | $9.54M derived: sum of 2 quarters · filed 2019-12-23 | $15.08M 10-Q · filed 2019-12-23 | $15.09M 10-Q · filed 2018-10-30 | $18.99M derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2018-06-30 | $5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $11.20M 10-Q · filed 2019-08-06 | $15.11M derived: sum of 3 quarters · filed 2020-03-02 | $18.01M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $5.54M 10-Q · filed 2019-05-10 | $9.45M derived: sum of 2 quarters · filed 2020-03-02 | $12.35M derived: sum of 3 quarters · filed 2020-03-02 | $14.66M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.81M derived: sum of 2 quarters · filed 2020-03-02 | $9.12M derived: sum of 3 quarters · filed 2020-03-02 | $12.47M 10-K · filed 2020-03-02 | $12.95M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $5.21M derived: sum of 2 quarters · filed 2018-10-30 | $8.56M 10-Q · filed 2018-10-30 | $9.96M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2017-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $5.66M 10-Q · filed 2018-08-03 | $7.06M derived: sum of 3 quarters · filed 2019-03-04 | $8.41M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2017-03-31 | $3.35M 10-Q · filed 2018-05-10 | $4.75M derived: sum of 2 quarters · filed 2019-03-04 | $6.09M derived: sum of 3 quarters · filed 2019-03-04 | $8.73M derived: sum of 4 quarters · filed 2019-03-04 | ||||
| 2016-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | $2.75M derived: sum of 2 quarters · filed 2019-03-04 | $5.38M derived: sum of 3 quarters · filed 2019-03-04 | $8.52M 10-K · filed 2019-03-04 | ||||
| 2016-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $3.98M derived: sum of 2 quarters · filed 2017-11-14 | $7.12M 10-Q · filed 2017-11-14 | $8.56M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $5.77M 10-Q · filed 2017-08-07 | $7.21M derived: sum of 3 quarters · filed 2018-03-01 | |||||
| 2016-03-31 | $3.13M 10-Q · filed 2017-05-12 | $4.58M derived: sum of 2 quarters · filed 2018-03-01 | ||||||
| 2015-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.28M 10-K · filed 2018-03-01 | ||||||
| 2015-09-30 | -$163.00K 10-Q · filed 2016-12-05 | |||||||
| 2014-12-31 | $2.56M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |